Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06793644 · ClinicalTrials.gov registry record
Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients
A clinical trial of Trauma Injury and Fractures, Bone, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06793644 is a study of Trauma Injury and Fractures, Bone that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 10 participants, below the 500-participant average among 15 other Trauma Injury trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06793644, a study of Trauma Injury and Fractures, Bone, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complication. This is important to help surgeons select the most appropriate treatment for severe traumatic injuries and infections.
Conditions Studied
Interventions
- DRUG Immunofluorescence Imaging
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2027-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06793644
The ClinicalTrials.gov registry entry for NCT06793644 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 500-participant average among 15 other Trauma Injury trials with a reported enrollment target (98% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Trauma Injury appearing as the primary indexed condition, and to 1 intervention - of which Immunofluorescence Imaging is the first listed.
NCT06793644 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06793644 about?
NCT06793644 is a clinical study titled "Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients". The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complica...
What is the current status of trial NCT06793644?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-06-10. Estimated completion is 2027-10.
What conditions does trial NCT06793644 study?
This clinical trial studies the following conditions: Trauma Injury, Fractures, Bone.
What interventions are being tested in trial NCT06793644?
The interventions under investigation include: Immunofluorescence Imaging (DRUG).
Who is sponsoring clinical trial NCT06793644?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06793644 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pathological Myeloid Activation After Sepsis and Trauma
RECRUITING
-
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
RECRUITING · NA
-
Antibiotic Use in Facial Fracture Post Injury
RECRUITING
-
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
RECRUITING · NA
-
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
RECRUITING
-
Bioimpedance for Ortho Trauma
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.